
The CVS/Aetna deal won’t kill traditional pharmacy-it just shows that it’s already dead.

The CVS/Aetna deal won’t kill traditional pharmacy-it just shows that it’s already dead.

Now that an official proposal has been announced, how are industry leaders responding?

Samples of the diabetes medication were contaminated.

Don’t know what to get your coworkers? Relax, we’ve got you covered.

Even if it doesn't happen, the deal says a lot about the current and future states of pharmacy.

Pharmacy has changed a lot in the last 70 years, and these old ads prove it.

Prenatal exposure to the common medication was linked to an increased risk of ADHD.

The new network will feature thousands of independents, but NCPA has reservations.

Another large company pledges its support for helping to fight the opioid epidemic.

It’s Halloween, which means it’s time to take a close look at the creepiest things affecting pharmacies.

Two companies have issued recalls on their products.

A judge tossed an award given to a woman claiming baby powder caused ovarian cancer.

Will Shingrix become the new go-to shingles vaccine?

The chain has entered into a 5-year agreement with Anthem’s IngenioRx.

Diabetes patients are making fatal errors with their insulin pens-pharmacists can help.

Pharmacists can help patients-but only the ones they have time to reach.

From the Drug Topics archives, one of most popular features in our history returns.

Governor Jerry Brown signed the bill, but will it actually lower drug costs?

Kiriko is recalling all lots of its weight-loss supplement.

A study finds that a significant number of FDA-mandated studies are unfinished.

The new ScriptPath Prescription Schedule system is expected to help patients and pharmacists.

Proponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?

What you need to know about the latest new medications.

A pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.

Sometimes the people on top make your life miserable.

A worldwide operation shuts down hundreds of illegal websites.

The chain’s PBM will limit opioid prescriptions, along with a host of other opioid safety programs.

New data show that health benefit costs in 2018 will rise by their highest since 2011.

The pharmacy is launching its #ItEndsWithUs campaign to educate teens.

Gottlieb says that changes may be coming, but remains firm on current regulations.